Compare HubSpot Inc (HUBS) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HubSpot Inc vs Inovio Pharmaceuticals Inc — how do they compare? HubSpot Inc trades at $217.99 (market cap $11.84B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). The key difference: HubSpot Inc is far larger — about 132.6× Inovio Pharmaceuticals Inc's market cap, and HubSpot Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| HUBS | INO | |
|---|---|---|
Market Cap | $11.84B | $89.27M |
Sector | Technology | Health |
52-Week High | $560.90 | $2.87 |
52-Week Low | $170.39 | $1.05 |
Enterprise Value | $10.39B | $60.28M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
